ArticleInternational journal of molecular sciences2025
Prognostic Value of Erythrogram Indicators and C-Reactive Protein Levels in Predicting Outcomes of Patients with Coronavirus Disease 2019.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Coronavirus disease 2019 (COVID-19) has posed unprecedented challenges to global public health, highlighting the importance of prognostic biomarkers in critically ill patients. The oxidative stress developed in COVID-19 is associated with impairment in various human organs and systems, and it is related to erythrocyte injury, leading to an elevation in red cell distribution width (RDW) and systemic inflammation. This study aims to assess the prognostic value of erythrogram indicators and C-reactive protein (CRP) levels in 91 intensive care unit-admitted COVID-19 patients, categorized into survivor patients (discharge group) and non-survivor patients (death group). The results were presented using descriptive statistics and the Mann-Whitney test. The most severe cases of respiratory failure in which the patients did not survive showed higher red cell distribution width (RDW) and lower values of red blood cell count, hemoglobin, and hematocrit. RDW may be an important indicator of mortality, as demonstrated by the receiver operating characteristic (ROC) curve analysis. Furthermore, this increase in RDW is correlated with elevated CRP levels, another important clinical outcome for these patients. In conclusion, elevated RDW and CRP levels at admission may be reliable predictors of unfavorable outcomes, emphasizing the utility of these indicators in clinical assessments of COVID-19 patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.